Enovis Corporation (ENOV) Stock Price
ENOVStock
$19.59−37.19%52W
Market Cap$1.13B
P/E—
PEG Ratio3.45
Div yield—
Beta1.44
ENOV Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-31.86%
Price vs S&P 500 (4W)9.92%
PEG Ratio3.45
VGM Score46.83
ENOV Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q2 2026 | $0.85 | $0.90 | +6.34%(+$0.05) | |
| Q1 2026 | $0.81 | $0.89 | +9.88%(+$0.08) | |
| Q4 2025 | $0.84 | $0.95 | +13.05%(+$0.11) | |
| Q3 2025 | $0.65 | $0.75 | +15.59%(+$0.10) | |
| Q2 2025 | $0.72 | $0.79 | +9.87%(+$0.07) |
ENOV Analyst Recommendations
Jun 2026
Jul 2026
Aug 2026
Sep 2026
4.22
4.24
4.21
4.21
Industry Peers — Orthopedic & Prosthetic Devices(31)
| Symbol | Value Score | Growth Score | Momentum Score | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|---|---|---|
ENOVEnovis Corporation | B | D | C | 0.5x | -6.0% | 61.4% | -45.1% | $19.59 |
| ISRGIntuitive Surgical Inc. | D | B | B | 13.7x | 18.2% | 66.7% | 31.3% | $426.70 |
| EWEdwards Lifesciences Corp | D | C | B | 7.7x | 6.7% | 77.8% | 18.2% | $86.60 |
| STESTERIS plc | C | C | B | 3.6x | 13.8% | 44.4% | 18.9% | $222.66 |
| ZBHZimmer Biomet Holdings, Inc. | B | C | B | 2.1x | 3.2% | 69.9% | 14.2% | $94.98 |
| SNNSmith & Nephew plc | B | C | C | 1.9x | 6.2% | 68.2% | 12.9% | $29.06 |
| ALGNAlign Technology Inc | B | D | C | 2.5x | 10.3% | 69.0% | 13.2% | $147.31 |
| MSAMine Safety Incorporated | C | C | B | 3.5x | 6.8% | 47.6% | 21.2% | $179.05 |
| ESTAEstablishment Labs Holdings Inc. | F | A | C | 7.2x | 20.0% | 70.5% | -7.6% | $59.18 |
| CDRECadre Holdings, Inc. | B | C | C | 1.6x | 8.6% | 41.8% | 10.1% | $26.38 |
| AVRAnteris Technologies Global Corp. Common Stock | D | C | C | 263.0x | — | 75.0% | -4738.4% | $6.05 |
About Enovis Corporation
Enovis manufactures orthopedic and rehabilitation devices for reconstructive surgery, injury prevention, and pain management. The company serves orthopedic specialists, primary care physicians, physical therapists, and athletic trainers, addressing musculoskeletal conditions ranging from sports injuries and deformities to degenerative diseases. Its Prevention & Recovery segment, which represents the majority of revenue, provides post-surgical rehabilitation and chronic condition management solutions.